Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,215.00    155.00 (3.06%)
Bid:
5,205.00
Ask:
5,215.00
Spread: 10.00 (0.192%)
Market Cap: £3.79b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Trading Statement

9 May 2018 07:00

RNS Number : 4154N
Renishaw PLC
09 May 2018
 

Renishaw plc

Trading update

9th May 2018

Ahead of the investor day being held tomorrow, we are providing a trading update as follows:

 

Renishaw plc, the global high-precision metrology and healthcare technology group, publishes this trading update for the nine months ended 31st March 2018. It contains unaudited information that covers the first three quarters and the period since.

 

Trading activity

 

Continuing operations

9 months to 31st March 2018

9 months to 31st March 2017*

Change

Metrology

£406.6m

£361.4m

+12.5%

Healthcare

£23.3m

£22.9m

+1.7%

Total Revenue

£429.9m

£384.3m

+11.9%

 

 

 

 

Adjusted* Profit before tax

£97.6m

£70.1m

+39.2%

Statutory Profit before tax

£104.4m

£69.7m

+49.8%

 

 

Revenue from continuing operations for the first three quarters of the current financial year was £429.9m, an increase of 11.9% compared with £384.3m for the corresponding period last year. We experienced underlying growth at constant exchange rates of 16.4%, with growth in all regions.

 

In our metrology business revenue amounted to £406.6m compared with £361.4m for the same period last year, with an underlying growth at constant exchange rates of 16.9%. Revenue in our healthcare business was £23.3m compared with £22.9m for the same period last year, an increase of 5.9% at constant exchange rates.

 

Adjusted* profit before tax from continuing operations for the first three quarters amounted to £97.6m compared with a restated adjusted* profit before tax of £70.1m for the corresponding period last year.

 

Financial position 

The Group balance sheet remains strong with net cash balances of £91.2m as at 31st March 2018 (30th June 2017: £51.9m).

 

Outlook

Notwithstanding current economic uncertainties, the Board remains confident in the future prospects of the Group. In our half year interim report, we forecast full year revenue to be in the range of £575m to £605m and adjusted profit before tax to be in the range of £127m to £147m. We continue to expect growth in both revenue and profit for this financial year and now expect full year revenue to be in the range of £585m to £610m and adjusted profit before tax to be in the range of £135m to £150m. Statutory profit before tax is expected to be in the range of £145m to £160m.

The preliminary full year results for the year ending 30th June 2018 will be released on 26th July 2018.

 

 

Sir David McMurtry William Lee

CBE, RDI, FRS, FREng, CEng, FIMechE Chief Executive Officer

Executive Chairman

 

9th May 2018

 

 

 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

LEI number 21380048ADXM6Z67CT18

Telephone number 01453 524524

Website www.renishaw.com 

 

 

* Adjusted profit before tax and prior year restatements

 

In the trading update issued on 10th May 2017, the cumulative profit before tax for the first three quarters of the financial year 2017 was reported as £69.3m. The results of the spatial measurement business have been excluded as this business has been reclassified as a discontinued activity, giving rise to an increase in profit before tax of £0.8m.

 

The adjustment to statutory profit relates to the accounting treatment of certain forward currency contracts used as hedging instruments which do not qualify for hedge accounting as they do not meet the hedge effectiveness criteria set out in the International Accounting Standard IAS39 'Financial Instruments: Recognition and Measurement'. The board deems that the adjusted profit before tax better reflects the underlying performance of the Group. The following table reconciles statutory profit before tax to adjusted profit before tax:

 

 

£'m

9 months to 31st March 2018

 

9 months to 31st March 2017

 

 

 

 

Profit before tax as previously reported

 

 

69.3

 

 

 

 

Restatement for discontinued operations

 

 

0.8

 

 

 

 

Restated adjusted profit before tax from continuing operations

97.6

 

70.1

 

 

 

 

Fair value gains/losses on financial instruments not eligible for hedge accounting

 

 

 

- reported in revenue

2.6

 

7.9

- reported in losses from the fair value of financial instruments

4.2

 

 (8.3)

 

 

 

 

Restated statutory profit before tax from continuing operations

104.4

 

69.7

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEASSPESAPEFF
Date   Source Headline
10th May 20121:26 pmRNSStatement re date of Interim Management Statement
25th Apr 201212:48 pmRNSDirectorate Change
16th Apr 20122:08 pmRNSDirector/PDMR Shareholding
25th Jan 20127:00 amRNSHalf Yearly Report
12th Dec 20111:44 pmRNSHolding(s) in Company
24th Oct 20118:17 amRNSDirector/PDMR Shareholding
13th Oct 20112:19 pmRNSResult of AGM
13th Oct 201111:26 amRNSHolding(s) in Company
13th Oct 201111:05 amRNSInterim Management Statement
7th Sep 20113:56 pmRNSAnnual Information Update
19th Aug 20118:56 amRNSAnnual Financial Report
12th Aug 20119:02 amRNSDirector/PDMR Shareholding
27th Jun 20111:30 pmRNSFacilities expansion plans
23rd Jun 201112:09 pmRNSHolding(s) in Company
17th May 20117:00 amRNSInterim Management Statement
26th Apr 20119:53 amRNSDirector/PDMR Shareholding
16th Mar 20113:17 pmRNSHolding(s) in Company
26th Jan 20117:00 amRNSHalf Yearly Report
24th Dec 20109:35 amRNSDirector/PDMR Shareholding
14th Oct 20102:29 pmRNSResult of AGM
14th Oct 201010:37 amRNSInterim Management Statement
9th Sep 20107:00 amRNSTrading Statement
1st Sep 20101:15 pmRNSAnnual Information Update
23rd Aug 20107:00 amRNSAnnual Financial Report
28th Jul 20107:00 amRNSFinal Results
23rd Jun 20101:51 pmRNSHolding(s) in Company - Replacement
23rd Jun 20101:50 pmRNSHolding(s) in Company - Replacement
23rd Jun 20101:43 pmRNSDirector/PDMR Shareholding
23rd Jun 20101:39 pmRNSDirector/PDMR Shareholding - Replacement
22nd Jun 201011:52 amRNSHolding(s) in Company
22nd Jun 201011:51 amRNSHolding(s) in Company
22nd Jun 201011:49 amRNSDirector/PDMR Shareholding
22nd Jun 201011:46 amRNSDirector/PDMR Shareholding
21st Jun 20105:32 pmRNSHolding(s) in Company
21st Jun 20105:23 pmRNSDirector/PDMR Shareholding
17th May 20109:32 amRNSDirector/PDMR Shareholding
14th May 20107:00 amRNSInterim Management Statement
23rd Apr 201011:50 amRNSDirector/PDMR Shareholding
23rd Apr 201011:03 amRNSDirector/PDMR Shareholding
27th Jan 201012:28 pmRNSHalf Yearly Report - Replacement
27th Jan 20107:30 amRNSHalf Yearly Report
19th Jan 20108:06 amRNSHolding(s) in Company
7th Dec 20097:00 amRNSTrading Statement
26th Nov 20099:49 amRNSDirector Declaration
15th Oct 20092:25 pmRNSResult of AGM
15th Oct 200911:06 amRNSInterim Management Statement
29th Sep 20097:30 amRNSTrading Statement
24th Aug 20098:51 amRNSAnnual Financial Report
29th Jul 20097:30 amRNSFinal Results
6th Jul 20097:44 amRNSCompany Secretary Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.